McKesson | MCK - Fremdkapital

Aktienkurs
898.95
Täglich Wechseln
-21.40 -2.33%
Monatlich
-5.12%
Jährlich
34.90%
Q1 Prognose
912.49




Fremdkapital Veränderung Datum
Acadia Healthcare USD 2.47B 186.76M 2025-12
Align Technology USD 0 0 2024-12
Cardinal Health USD 8.35B 633M 2025-12
Centene USD 17.35B 194M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 30.95B 4.47B 2025-09
Community Health Systems USD 10.38B 209M 2025-12
Computer Programs Systems USD 161.36M 1.74M 2025-09
CVS Health USD 60.5B 6M 2025-12
DaVita Healthcare Partners USD 10.16B 19.88M 2025-12
Dentsply International USD 2.02B 2M 2025-12
eHealth USD 69.42M 965K 2025-09
Elevance Health USD 30.8B 376M 2025-12
Encompass Health USD 2.45B 53.3M 2025-12
HCA USD 41.6B 3.2B 2025-12
Henry Schein USD 2.31B 157M 2025-12
Humana USD 12.37B 238M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
J&J USD 39.44B 30M 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
McKesson USD 5.43B 586M 2025-12
Molina Healthcare USD 3.95B 98M 2025-12
Owens Minor USD 1.8B 35.38M 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Stryker USD 14.86B 14M 2025-12
Tenet Healthcare USD 13.09B 10M 2025-12
UnitedHealth USD 72.32B 79M 2025-12
Universal Health Services USD 4B 53.46M 2025-12
Veradigm USD 200.4M 69K 2022-12